Litigation Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

Docket		Date Filed	2018-05-01
Court	District Court, D. Delaware	Date Terminated	2022-07-28
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	ZYDUS PHARMACEUTICALS (USA) INC.
Patents	10,232,003; 10,406,172; 6,414,126; 6,515,117; 7,851,502; 7,919,598; 7,943,582; 7,943,788; 8,221,786; 8,222,219; 8,361,972; 8,501,698; 8,513,202; 8,551,957; 8,685,934; 8,716,251; 8,785,403
Attorneys	Alan B. Clement
Firms	Phillips, McLaughlin & Hall, P.A.
Link to Docket	External link to docket

Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-10-19	102	Notice of Service	Invalidity of the Asserted Claims of U.S. Patent No. 6,515,117; (2) the Reply Expert Report of Garry Tobin…Invalidity of the Asserted Claims of U.S. Patent No. 6,515,117; and (3) the Expert Report of Radojka Savic…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-06-22	11	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,851,502 ;7,919,598 ;8,221,786…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-01-25	128	Redacted Document	ANDA Products”) infringes U.S. Patent No. 6,515,117 (“the ’117 patent”); WHEREAS, Zydus has …has asserted that the claims of the ‘117 patent are invalid and, therefore, not infringed; WHEREAS…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-05-11	139	Redacted Document	232:2 H, L, R 231:2 232:4-10 232:3 232:17-25 233:2-3 … U.S. Patent No. 6,774,112 (“the ’112 patent”) on August 10, 2004. 90. U.S. Patent Application… preclude patentability”). 17. When a patent challenger contends that a patent is obvious…Its NDA, and the ’117 Patent 1. This is a civil action for patent infringement, arising …AstraZeneca’s Orange Book-listed U.S. Patent No. 6,515,117 (“the ’117 patent”). One indication of FARXIGA®	External link to document
2021-06-14	145	Exhibit List	May 17 | “Vier | semen, | United States Patent No. 6,515,117 0004 May 17 |", | “"""…quot;"| Certified File History for U.S. Patent 6,515,117 0027 May 17 Gribble | Gribble |Confidential…0090 May 17 | Gribble | Gribble | United States Patent No. 7,863,327 - Gribble et al. 0091 May 17 IGribble…USA) Inc.'s Invalidity Contentions for U.S. Patent Nos. 7,943,788; 8,785,403 & 8,785,403 01 54…iemaay’ | Certified File History for United States Patent Application No. 16/014,479 0263 May 18 | Batchelor	External link to document
2021-10-15	170	Opinion	for infringement of U.S . Patent Nos. 6,414,126 ("the ' 126 patent") and 6,515,117 ("…the '117 Patent (PTX0242 at 183) Claims 14 and 16 of the ' 117 patent teach methods …quot;the ' 117 patent") under 35 U.S.C. § 271(e)(2)(A). (D.I. 1). I held a four-day bench trial…validity of claims 1-3, 14, and 16 of the ' 117 patent. (D.I. 135, ,rs ; Tr. at 2:22-3:1; see D.I. 66 … BACKGROUND The '117 patent is directed to compounds and methods for treatment	External link to document
2022-05-20	184	Letter	expiration date of the patent-at-issue, U.S. Patent No. 6,515,117 (“the ’117 patent”), was October 4, 2020…2020, the United States Patent & Trademark Office issued a certificate on July 29, 2020, extending…extending the term of the ’117 patent by five years under 35 U.S.C. § 156. (Ex. A; see also D.I. 135-1, Ex. A… ¶ 24.) The current expiration date of the ’117 patent is therefore October 4, 2025. (See id.) Accordingly…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document